For years, Chiesi Italia has been working with innovative companies in various fields and sectors: from insight production to innovative ways of contact with doctors and patients. As a recognised and established company in the pharmaceutical sector, Chiesi Italia is able to offer companies and startups applying through the innovHub platform, an environment filled with opportunities to grow, develop and succeed in the competitive pharmaceutical sector.
Companies and startups can benefit from access to a large network of experienced professionals in various fields of the pharmaceutical industry, including research and development, regulation, manufacturing and marketing.
Chiesi can provide mentorship and technical support to companies and startups, helping them overcome industry-specific technical challenges and accelerating their development process.
Navigating the complex regulatory landscape of the pharmaceutical sector can be a big challenge for companies and startups. Chiesi can offer support to ensure compliance with national and international regulations.
Participating in an ecosystem such as InnovHub offers companies and startups the opportunity to increase their visibility, and establish valuable contacts with other stakeholders in the sector.
Chiesi can provide access to its distribution channels and market networks to companies and startups, helping them to expand their reach and attain new customers.
Chiesi could offer funding or direct investment to companies and startups with a high potential, helping them overcome initial financial challenges and scale their operations.
Collaborating with a company such as Chiesi can bring significant validation and credibility to a company or startup. This can be especially valuable for startups in the early stages of development, to help them gain trust from investors, partners and customers.
Chiesi can assist companies and startups in defining and implementing effective business and marketing strategies, using its experience and market knowledge.
Chiesi Italia's commitment to sustainability and its decision to become a Benefit Company with the aim of integrating not only the economic variable, but also purposes of common benefit in its choices, by creating a positive impact on society and the environment around us, can guide companies and startups on their path towards more sustainable practices.
Companies and startups can benefit from training and professional development programmes, to improve their team's skills in key areas of the pharmaceutical business.
In line with its vision as a sustainable company and its commitment to sustainability issues, Chiesi achieved the B CORP certification in 2019, thus becoming part of a global community of companies that meet high social and environmental standards.
Headquartered in Parma, Italy, Chiesi has over 85 years of experience, operates in 31 countries and employs more than 6,500 people. Our R&D centre in Parma collaborates with six other major R&D centres in France, the US, Canada, China, the UK and Sweden.
For further information, please visit www.chiesi.com